Remote monitoring of pacemakers and defibrillators: Effective and safe in Brazil?

• Published in: Heart rhythm O2 2022-12, Vol.3 (6), p.736-742
• Main Authors: Rocha, Maria Eduarda Quidute Arrais, Lima, Neiberg de Alcantara, Pinho, Luís Gustavo Bastos, Gondim, David Sales Pereira, Miná, Camila Pinto Cavalcante, Rocha, Eduardo Augusto Quidute Arrais, Rocha, Maria Camila Timbó, Nobre, Juvêncio Santos, Pereira, Francisca Tatiana Moreira, Prakash, Preeya, Maia, Fernanda Pimentel Arraes, Rocha, Eduardo Arrais
• Format: Article
• Language: English
• Subjects: Brazil; Clinical; Implantable cardioverter-defibrillator; Middle-income countries; Pacemaker; Remote monitoring
• ISSN: 2666-5018; 2666-5018
• DOI: 10.1016/j.hroo.2022.10.001

The remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) has become a common method of in-home monitoring and follow-up in high-income countries given its effectiveness, safety, convenience, and the possibility of early intervention. However, in Brazil, RM is still underutilized. This observational study aims to demonstrate our experience of using RM in Brazil and the predictive factors of RM of CIED follow-up in Brazil. This was a prospective cohort study of patients with a CIED. Event rates are reported and clinical responses to those findings and outcomes based on the detection of RM. A logistic regression model was performed to identify predictors of more events, with P < .05 for statistical significance. This study evaluated consecutive 119 patients: 30.2% with pacemakers, 42.8% with implantable cardioverter-defibrillator, 22.7% with cardiac resynchronization therapy (CRT) with defibrillator, and 3.3% with CRT with pacemaker. Events were detected in 63.9% of the cases in 29.5 ± 23 months of follow-up. The outcomes found were that 44.5% needed elective evaluation in medical treatment and 23.5% needed immediate evaluation in therapy. Logistic regression analysis showed that the groups with CRT or CRT with defibrillator (75.0%), reduced ejection fraction (76.5%), and New York Heart Association functional class ≥II (75.0%) had the highest RM event rates. RM proved to be effective and safe in the follow-up of patients with CIEDs in Brazil, allowing early interventions and facilitating therapeutic management.